نتائج البحث

Design and rationale of the EMPA‐VISION trial: investigating the metabolic effects of empagliflozin in patients with heart failure

• Authors : Moritz J. Hundertmark; Olorunsola F. Agbaje; Ruth Coleman

Subjects: Heart failure; Diabetes; SGLT2 inhibitors

• Source: ESC Heart Failure, Vol 8, Iss 4, Pp 2580-2590 (2021)

تفاصيل العنوان

Empagliflozin improves cardiac energetics during ischaemia/reperfusion by directly increasing cardiac ketone utilization:EMPA increases cardiac ketone utilisation independent of supply

• Authors : Chase, Dylan; Eykyn, Thomas R; Shattock, Michael J

Subjects: SGLT2 inhibitors; ischaemia/reperfusion; substrate metabolism

• Source: Chase , D , Eykyn , T R , Shattock , M J & Chung , Y J 2023 , ' Empagliflozin improves cardiac energetics during ischaemia/reperfusion by directly increasing cardiac ketone utilization :

تفاصيل العنوان

Longitudinal Changes in Circulating Ketone Body Levels in Patients With Acute Heart Failure:A Post Hoc Analysis of the EMPA-Response-AHF Trial

• Authors : Voorrips, S. N.; Boorsma, E. M.; Beusekamp, J. C.

Subjects: acetone; Acute heart failure; empagliflozin

• Source: Voorrips , S N , Boorsma , E M , Beusekamp , J C , de Boer , R A , Connelly , M A , Dullaart , R P F , van der Meer , P , van Veldhuisen , D J , Voors , A A , Damman , K & Westenbrink , B D 2023 , '

تفاصيل العنوان

Following the results of the EMPA-REG OUTCOME trial with empagliflozin, is it possible to speak of a class effect?

• Authors : Ampudia-Blasco FJ; Romera I; Ariño B

Subjects: cardiovascular; outcome studies; SGLT2 inhibitors

• Source: International Journal of General Medicine, Vol Volume 10, Pp 23-26 (2017)

تفاصيل العنوان

Vascular legacy: HOPE ADVANCEs to EMPA-REG and LEADER: A Surprising similarity

• Authors : Sanjay Kalra; Rakesh Sahay

Subjects: ACE inhibitors; cardio-cerebral dissociation; cardiovascular outcome trial

• Source: Indian Journal of Endocrinology and Metabolism, Vol 21, Iss 1, Pp 245-248 (2017)

تفاصيل العنوان

Empagliflozin Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients (EMPA-REG OUTCOME) 연구: 실제 임상에서 처방 패턴이 변할 것인가?

• Authors : 권혁상¹

• Source: Journal of Korean Diabetes. 2016, Vol. 17 Issue 4, p225-232. 8p.

تفاصيل العنوان

Vascular legacy: HOPE ADVANCEs to EMPA-REG and LEADER: A Surprising similarity.

• Authors : Kalra, Sanjay¹ ; Sahay, Rakesh²

• Source: Indian Journal of Endocrinology & Metabolism. Jan/Feb2017, Vol. 21 Issue 1, p245-248. 4p.

تفاصيل العنوان

Bladder cancer in the EMPA-REG OUTCOME trial

• Authors : Jisoo Lee; Bernard Zinman; Silvio E. Inzucchi

Subjects: Oncology; medicine.medical_specialty; Letter

• Source: Diabetologia

تفاصيل العنوان

Efficacy of empagliflozin on heart failure and renal outcomes in patients with atrial fibrillation: data from the EMPA-REG OUTCOME trial.

• Authors : Böhm, Michael¹ (AUTHOR) ; Slawik, Jonathan¹ (AUTHOR); Brueckmann, Martina^2,3 (AUTHOR)

• Source: European Journal of Heart Failure. Jan2020, Vol. 22 Issue 1, p126-135. 10p. 1 Diagram, 2 Charts, 5 Graphs.

تفاصيل العنوان

Similarities and distinctions between acetazolamide and sodium–glucose cotransporter 2 inhibitors in patients with acute heart failure: Key insights into ADVOR and EMPULSE.

• Authors : Packer, Milton^1,2 (AUTHOR) ; Butler, Javed^3,4 (AUTHOR)

• Source: European Journal of Heart Failure. Sep2023, Vol. 25 Issue 9, p1537-1543. 7p. 1 Chart, 1 Graph.

تفاصيل العنوان